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Summary
Recently, we found that high levels of clotting factor VIII
(>150 lU/dl) are common and make an important contribution to
thrombotic risk. The determinants of high factor VIII:C are unclear and
might be partly genetic. Therefore, we tested the influence of age, blood
group and von Willebrand factor (VWF) levels on factor VIII:C
levels, and investigated whether factor VIII:C levels are genetically
determined. We performed an analysis of 564 female relatives of
hemophilia A patients, who had visited our center for genetic
counseling. In univariate analysis, ABO blood group, age and VWF
antigen (VWF:Ag) levels all influenced factor VIII:C levels. After
adjustment for the effect of VWF:Ag levels, both blood group and age
still had an effect on factor VIII:C levels. In sister pairs, the Pearson
correlation coefficient between factor VIII:C levels was 0.17
(p = 0.024) and this correlation remained positive (0.15, p = 0.046)
after correction for the influence of VWF:Ag. In mother-daughter pairs,
no correlation of factor VIII:C levels was found. The correlation
of VWF:Ag levels in sisterpairs was 0.41 (p <0.001) and in
mother-daughter pairs 0.44 (p <0.001), in line with the assumption
that VWF:Ag levels are under control of autosomal genes. Familial
influence on plasma factor VIILC and VWF:Ag levels was investigated
with a recently developed familial aggregation lest. This lest verifies
whether familial aggregation of a particular parameter exists in a set of
pedigrees. In 435 women from 168 families, factor VIII:C äs well äs
VWF:Ag levels correlated significantly wilhin families, which suggests
a familial influence. The familial aggregation was more prominent for
VWF:Ag levels than for factor VIII:C levels, possibly because the
genetic effect on VWF:Ag levels is larger than on factor VIILC levels.
Our results support the presence of a familial influence on factor
VIILC äs well äs on VWF:Ag levels.
Introduction
Several studies have indicated an association of the levels of clotting
factor VIII:C and von Willebrand factor antigen (VWF:Ag) with
arterial thrombosis (1-4). We have repeatedly found a low
mortality of ischaemic heart disease in hemophiliacs (5, 6), whereas
high factor VIII:C and VWF:Ag levels have been reported to be
associated with ischaemic heart disease (3, 4). Higher risks of arterial
Correspondence to: Dr. Pieter W. Kamphuisen, Hemostasis and Thrombosis
Research Center, University Hospital, Building l, C2-R, PO Box 9600,
2300 RC Leiden, The Netherlands - Tel.: +3171 5262267; FAX Number
+3171 5266755; E-mail: kamphuisen_p@rullf2.medfac.leidenuniv.nl
thrombosis have also been reported for individuals with blood group
non-0 (3, 7), m whom factor VIII:C and VWF:Ag concentrations are
higher than m individuals with blood group 0 (8,9).
Recently, we investigated the roles of ABO blood group, VWF:Ag
and factor VIII:C levels in the occurrence of deep-vein thrombosis (10).
Non-0 blood group and high concentrations of VWF:Ag and factor
VIILC increased the risk of deep-vein thrombosis. In multivariate
analysis, the effect of non-0 blood group and VWF:Ag was fully
explained by factor VIH:C, i.e. factor VIII:C appeared to be the final
effector in promoting deep-vein thrombosis. The prevalence of factor
VIII:C concentrations > 150 lU/dl was 25% in thrombosis patients and
11% in healthy control subjects, which led to an adjusted odds ratio of
4.8 (95% CI 2.3-10.0) for venous thrombosis. We concluded that high
levels of factor VIII:C are common and therefore make an important
contribution to the risk of deep-vein thrombosis.
The large mterindividual Variation in both plasma factor VIILC
and VWF:Ag levels can be explained by blood group, age and several
other factors (11-13). VWF:Ag is an important contributor to
the factor VIII:C concentration, which is explained by VWF being the
carrier protein for factor VIII. The non-bound factor VIII is partic-
ularly unstable in the circulation (14, 15). In the 1960s and 1970s,
family studies indicated a genetic influence on the level of factor VIII:C
(16, 17). More recently, 0rstavik et al. (18) found that the variance of
factor VIII coagulation antigen (VHICag) and factor VHI-related
antigen (VIIIRag, i.e. VWF:Ag) levels was smaller within than
between twin pairs, with a heritability estimate of 0.57 for factor
VHICag and 0.66 for factor VIIIRag. This points to genetic deter-
minants of factor VIILC levels, additional to VWF.
Investigation of heritability is complicated and places high demands
on the group that is studied, with regards to structure and sample size.
Therefore, an essential preliminary procedure is to test correlations
between relatives.
With the current analysis, we had two aims. First, to quantify
the determinants of the factor VIII:C levels, i.e. age, blood group
and VWF, and to study to what extent the effect of blood group and
age on factor VIILC levels is influenced by VWF:Ag levels. Second,
to investigate whether factor VIILC levels are genetically deter-
mined.
These analyses require data on a large number of families. This may
take many years to collect. We realized that factor VIILC had been
measured for many years in families for carrier testing in hemophilia A.
This study was therefore performed within the database of families seen
for genetic counseling for hemophilia A. The familial aggregation
of plasma factor VIILC and VWF:Ag levels of 435 women from
168 families was investigated with a recently developed statistical test
that verifies the existence of familial aggregation (19).
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Fig. l Distribution of factor VIII:C levels for non-carriers (A) and carriers
(B) in relation with age and blood group 0 (O) and non-0 (·)
Materials and Methods
Family Data
Female relatives of probands with documented hemophilia A who came to
the Leiden hemophilia center for carriership testing between 1985 and 1995
were mcluded. Carriership was investigated using segregation analysis of
intra- and extragenic polymorphic markers of the factor VIII gene or of the
deleterious mutation m the family (20). In this way it could be clearly
established in 564 women from 172 families whether they were carriers of the
diseased allele or not. All subjects were first- or second-degree relatives of the
probands The pedigree size ranged from 2 (mother-daughter) to 8 persons.
Laboratoty Assays
Blood was collected from the antecubital vein in 0.106 mM trisodium
citrate. Factor VIII coagulant activity was measured by one-stage clotting
assays with factor VIII deficient plasma. Before 1991, VWF:Ag was
determined by Laurell immunoelectrophoresis. From 1991, VWF:Ag was
measured by an ELISA using polyclonal antisera. Pooled normal plasma
calibrated against an in-house reference, contaming 92 lU/dl VWF:Ag and
93 lU/dl factor VIII:C (relative to the WHO international Standard) was used äs
a reference.
Statistical Analysis
The distribution of both factor VHI:C and VWF:Ag was not normal, so they
were logarithmically transformcd for all statistical analyses. To investigate the
association between factor VIII:C and VWF:Ag, the correlation coefficient
(product moment) was used. To assess the effect of carriership, blood group
and age on factor VIII:C levels, we used multiple linear regression. Carriership,
äs determined by DNA analysis, was entered into the regression models äs a
dichotomous variable (0 for non-carriers, l for carriers), age äs a cöntinuous
variable (in years). Blood group was dichotomized into two groups (0 for blood
group 0, l for non-0). To lest whether the effect of age and blood group on
factor VIII:C was independent of VWFiAg level, VWF:Ag was added later in
the regression model äs a cöntinuous variable. Potentially confounding effects
of the different VWF:Ag assays were adjusted by multiple regression, which
did not lead to any differences.
To investigate the genetic influence on factor VIII:C and VWF:Ag levels,
the residuals of the multiple regression models were used. Residuais are the
differences between the observed level Y; for person / and the predicted value
μ, obtained from the multiple regression model. As a first lest for familial
effects, correlations between the residuals (obtained from the multiple regres-
sion model) of mother-daughter pairs and sister pairs were calculated. Between
all mother-daughter pairs, for which Υ,-μ, and Υ;-μ^ are the residuals of mother




Familial aggregation of factor VIII:C and VWF:Ag levels was studied using
a recently developed method (19), that tests the null hypothesis of no correla-
tion within randomly chosen pedigrees. Since we adjust for carriership by
multiple regression in these families, this lest can be used. Within pedigrees,
the correlation of the genetic effects is assumed to have the following natural
correlation structure R: parent-offspring and individuals within a sibship:
correlation 1/2, grandmother-granddaughter and aunt-niece: correlation 1/4,
etc. To combine all Information about correlations within a pedigree, Q can be
applied äs the weighted sum of correlations between pairs of relatives within a
pedigree. Its mathematical formula reads:
ß=? T -
* 4 4 -L
«=/;=/
R is the natural correlation between person i and / of the same pedigree
(1/2, 1/4 etc.). Rl; = 0 if person i and;' are not related. The value of Q is deter-
mined mamly by sibship and parent-child relations, but the other relationships
also contribute to the value of Q. The lest for familial aggregation is positive
when the calculated Q is significantly larger than the expecled Q value under
the null hypothesis of no aggregation. See reference 19 for details on the calcu-
lation of the associated p-value.
Results
We included 564 women from 172 families, who were all tested for
carriership for hemophilia A. Because of the possible effect of blood
group on factor VIII:C levels, all analyses were restricted to individuals
in which blood group was measured. 129 females were therefore ex-
cluded: In 4 families, containing 25 subjects, blood group was not
Table l Increase in factor VIII:C* (lU/dl) and in VWF:Ag levels (lU/dl) in relation to age and blood group












* Factor VIII:C levels adjusted for carriership
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analyzed, and in 37 famihes blood group was analyzed in one member
only, leaving out 104 persons. Of those 37 famihes, we included the
one member with known blood group äs a reference in the familial
aggregation lest. So 435 subjects from 168 families were eligible for
analyses. The mean age was 35 years (ränge 3-84). 193 women were
carriers of hemophiha A and 242 were non-carriers.
Factor VIII:C levels were strongly correlated (r = 0.58) with
VWF:Ag levels. Factor VlII:C levels were higher in the 227 subjects
with blood group non-0 than in the 208 persons with blood group 0
in both carriers and non-carriers (Fig l). As shown in Table l , after
correction for carriership, factor VIII:C concentrations in subjects with
blood group non-0 were 22.4 lU/dl (95% CI 15.1-31.2) higher than
those with blood group 0. For VWF:Ag levels this difference was
31.5 lU/dl (22.4-41.3). Both factor VIII:C and VWF:Ag levels
increased with age. For every successive 10 years of age, the factor
VIILC level increased 5.6 lU/dl and the VWF:Ag level 5.8 lU/dl.
To see whether the effect of blood group and age on factor VIII:C
concentration depended on VWF:Ag level, we used multiple linear
regression. After adjustment for the influence of VWF:Ag level, the
regression coefficient for blood group decreased to 9.3 lU/dl (2.8-16.2)
and for age to 3.l lU/dl (l.2-5.l) suggesting a VWF:Ag-mediated effect
of these variables on factor VIILC level (Fig 2). Nevertheless, blood group
and age still had an effect on factor VII1:C, independent of VWF:Ag.
To lest for correlations of factor VIILC and VWF:Ag levels within
mother-daughter and sister pairs, we analyzed all combinations of these
familial relationships. As shown in Table 2, after adjustment for blood
group and age, correlations for factor VIII:C levels between mother and
daughter were very weak (r = 0.08). In sister pairs this correlation was
0.17 (p = 0.024) and remained significant (r = 0.15, p = 0.042) after
correction for the influence of VWF:Ag level. VWF:Ag levels showed
a strong association in mother-daughter pairs (r = 0.44, p <0.001) and
sister pairs (r = 0.4l, p <0.00l).
Table 3 shows the results of the familial aggregation test for factor
VIII:C and VWF:Ag levels. In this test, the null hypothesis of no
correlation was rejected for both factor VIII:C and VWF:Ag levels.
For factor VIII:C Q was 469 (p = 0.028), whereas the expected value of
no correlation was 429. For VWFiAg level Q was 606 (p <0.00l).
After correction for VWF:Ag level, Q for factor VIII:C levels was 464
(p = 0.04) and was thus not essentially affected, suggesting that
familial influence on factor VIII:C levels is not regulated through
VWF:Ag levels alone.
Discussion
In this sludy we used a new test, the familial aggregation test, spe-
cifically developed for testing correlations between family members,
which uses all possible combinations in families and provides more
Information than the analysis of variance between pairs of relatives.
In the familial aggregation test, both factor VIII:C and VWF:Ag
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Fig. 2 Mean (O, ·) and predicted (---) factor VII1:C levels for age and
blood group. Factor VIII:C levels were adjusted for carriership (m A) and
for carriership äs well äs for the influence of VWF:Ag levels (in B). Predicted
values for age and blood group were calculated by multiple regression. The
difference in factor VIILC levels between blood group 0 and non-0 becomes
smaller after the correction for the influence of VWF:Ag levels, but is still
present
We found a positive correlation of factor VIII:C levels in sister pairs
only and not in mother-daughter pairs. For X-linked determinants it can
be predicted that factor VIII:C levels should give higher correlations in
sisters pairs than in mother-daughter pairs, because sisters inherit the
same X-chromosome from their father. This means that on average
50% of the sisters will have the same combination of X-chromosomes,
in contrast to 25% for autosomes. These findings suggest a control of
factor VIII:C Variation by X-linked alleles, possibly the factor VIII
gene itself. Filippi et al. (21) suggested a primary role of X-linked
genetic determinants in the Variation of factor VIII:C levels within
families. They found a positive correlation within groups of male pairs,
only if they had identical X-alleles.
VWF:Ag levels were strongly correlated in bolh mother-daughter
and sister pairs, which is in agreement with previous publications
that VWF:Ag levels are under control of autosomal genes (16, 22).
Table 2 Correlation coefficients of factor VIII:C and VWF:Ag levels between mother-daughter and sister pairs*






0.8 (p = 0.26)
0.17 (p = 0.024)
0.07 (p = 0.33)
0.15 (p = 0.046)
0.44(p<0.001)
041(p<0.001)
* Factor VI1I:C levels adjusted for carriership, age and blood group; VWF:Ag levels adjusted for age and blood group
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Table 3 Familial aggregalion of factoi VIII C and VWF Ag levels m 168 families*
Factor VIII C Factor VIII C














* Factor VIII C levels adjusled for camership agc and blood group VWF Ag levels adjusted foi age and blood group
Furthermore, m the Q test famihal aggregation was prominent,
indicatmg that VWF Ag levels among women were stongly influenced
by famihal factors
VWF Ag levels showed higher correlations m sister pairs than factor
VIIIC levels Assuming X-hnked regulation of factor VIII C levels,
one would expect the opposite One possible explanation is that the
genetic mfluence on VWF Ag levels is larger than on factor VIIIC
levels This hypothesis is supported by the higher Q we found for
VWF Ag levels in the famihal aggregation test Another possibihty is
that the adjustment of factoi VIII C levels for the mfluence of VWF Ag
levels is not correct, e g because we consider the mteraction between
factor VIII and VWF to be similar m all mdividuals It is possible
however, that different bmdmg affimties between VWF and factor VIII
result m a Variation of factor VIII levels m plasma Such different
affimties might be due to vanations m either the factor VIII or VWF
protem
Both factor VIII and VWF Ag levels are also influenced by blood
group and age 0rstavik and coworkers (18) found that the effect of
blood group and age on factor VIII level was secondaiy to the effect on
VWF Ag In our data, factor VIII C and VWF Ag levels increased with
age, an effect that persisted for factor VIIIC after adjustment for the
mfluence of VWF Ag levels This small mdependent effect of age on
factor VIIIC may be mediated through several other variables, such äs
body mass mdex, or the concentration of tnglycendes and fibnnogen,
that also increase with age and are positively correlated with the factor
VIIIC concentration (11 13) It is also possible that age has a
moie dnect mfluence on factor VIIIC levels by mcreasmg the activity
of transcnption factors bmdmg to the pi omotor of the factor VIII gene
Individuais with blood group non-0 had higher levels of factor VIIIC
and VWF Ag than subjects with blood group 0 Most of the Variation
m factor VIIIC levels caused by the effect of blood group was
mediated through VWF Ag However, usmg multiple regression
analysis, blood group still resulted m a predicted change in factor
VIIIC concentration of 9 3 lU/dl aftcr the correction for the effect of
VWF Ag levels In our pievious study, an effect of blood group on
factor VIII C of 7 6 lU/dl was noüced (10) How ABO blood group
mfluences plasma concentrations of VWF Ag and factor VIIIC is
unknown Blood group A, B, and H(0) ohgosacchande stiuctures have
been identified on the factor VIII/vWF complex and on punfied VWF
(23, 24) It is possible that blood group determmants not only mfluence
the plasma concenlration of VWF Ag but also the activity of factor
VIII C, e g by affectmg its secretion, activity or degradation (8) The
direct mfluence of blood group äs well äs age on factor VIII C levels
diffeis from the fmdmgs by 0rstavik et al (18) and may be explamed
by the fact that in their study factor VIII C antigen was measured
mstead ot factor VIII clottmg activity To conclude, VWF Ag levels
and faclor VIII C levels seem to be genetically determmed Factor
VIII C levels are influenced by age, blood group and other famihal
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Recent discovenes have established the endothehum äs a very large and
highly active endocnne organ which, through its Strategie Situation be-
tween the blood and the rest of the body, is responsible for a host of vital
physiological functions This m turn is leadmg to rapid advances m under-
standing the pathogenesis of some of the most senous and most common
diseases, includmg hypertension, atherosclerosis, and mflammation Edi-
tors and authors are internationally leadmg scientists m these investiga-
tions
For the endothelium, äs for all other tissues, morphological techmques,
however mgeniously applied, can provide no more than successive snap-
shots of contmuous dynamic processes 1t is only m more recent years (hat
these techmques have been supplemented by cell culture m vitro and by
mgenious uses of endothelial mediators m vivo Neverthe ess, many of the
most important questions about endothelial functions remam to be an-
swered It is the purpose of this book to mdicate directions along which
answers may be found
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